EP0799056 - USE OF A NK-1 RECEPTOR ANTAGONIST AND AN OPIOID ANALGESIC [Right-click to bookmark this link] | |||
Former [1997/41] | USE OF A TACHYKININ ANTAGONIST AND AN OPIOID ANALGESIC | ||
[2001/15] | Status | No opposition filed within time limit Status updated on 31.01.2003 Database last updated on 31.08.2024 | Most recent event Tooltip | 06.08.2004 | Lapse of the patent in a contracting state New state(s): LU | published on 22.09.2004 [2004/39] | Applicant(s) | For all designated states MERCK SHARP & DOHME LTD. Hertford Road Hoddesdon, Hertfordshire EN11 9BU / GB | [N/P] |
Former [1997/41] | For all designated states MERCK SHARP & DOHME LTD. Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | Inventor(s) | 01 /
HILL, Raymond, George Terlings Park Eastwick Road Harlow Essex CM20 2QR / GB | [1997/41] | Representative(s) | Hiscock, Ian James, et al European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB | [N/P] |
Former [1997/41] | Hiscock, Ian James, et al European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB | Application number, filing date | 95940386.6 | 15.12.1995 | [1997/41] | WO1995GB02931 | Priority number, date | GB19940026102 | 23.12.1994 Original published format: GB 9426102 | [1997/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9620009 | Date: | 04.07.1996 | Language: | EN | [1996/30] | Type: | A1 Application with search report | No.: | EP0799056 | Date: | 08.10.1997 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.07.1996 takes the place of the publication of the European patent application. | [1997/41] | Type: | B1 Patent specification | No.: | EP0799056 | Date: | 27.03.2002 | Language: | EN | [2002/13] | Search report(s) | International search report - published on: | EP | 04.07.1996 | Classification | IPC: | A61K45/06 | [1997/41] | CPC: |
A61K45/06 (EP,US);
A61P25/04 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1997/41] | Title | German: | VERWENDUNG VON NK-1 RECEPTOR ANTAGONISTEN MIT OPIOID-ANALGETIKA | [2001/15] | English: | USE OF A NK-1 RECEPTOR ANTAGONIST AND AN OPIOID ANALGESIC | [2001/15] | French: | UTILISATION D'UN ANTAGONISTE DU RECEPTEUR NK-1 ET D'UN ANALGESIQUE OPIOIDE | [2001/15] |
Former [1997/41] | VERWENDUNG VON TACKYKININ-ANTAGONISTEN MIT OPIOID-ANALGETIKA | ||
Former [1997/41] | USE OF A TACHYKININ ANTAGONIST AND AN OPIOID ANALGESIC | ||
Former [1997/41] | UTILISATION D'UN ANTAGONISTE DE LA TACHYKININE ET D'UN ANALGESIQUE OPIOIDE | Entry into regional phase | 23.07.1997 | National basic fee paid | 23.07.1997 | Designation fee(s) paid | 23.07.1997 | Examination fee paid | Examination procedure | 21.05.1996 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.07.1997 | Examination requested [1997/41] | 25.05.2000 | Despatch of a communication from the examining division (Time limit: M06) | 30.11.2000 | Reply to a communication from the examining division | 16.03.2001 | Despatch of communication of intention to grant (Approval: No) | 14.08.2001 | Despatch of communication of intention to grant (Approval: later approval) | 10.09.2001 | Communication of intention to grant the patent | 20.12.2001 | Fee for grant paid | 20.12.2001 | Fee for publishing/printing paid | Opposition(s) | 30.12.2002 | No opposition filed within time limit [2003/12] | Fees paid | Renewal fee | 02.01.1998 | Renewal fee patent year 03 | 04.01.1999 | Renewal fee patent year 04 | 05.01.2000 | Renewal fee patent year 05 | 02.01.2001 | Renewal fee patent year 06 | 02.01.2002 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 27.03.2002 | BE | 27.03.2002 | CH | 27.03.2002 | GR | 27.03.2002 | LI | 27.03.2002 | NL | 27.03.2002 | DK | 27.06.2002 | PT | 27.06.2002 | SE | 27.06.2002 | LU | 15.12.2002 | IE | 16.12.2002 | [2004/39] |
Former [2004/01] | AT | 27.03.2002 | |
BE | 27.03.2002 | ||
CH | 27.03.2002 | ||
GR | 27.03.2002 | ||
LI | 27.03.2002 | ||
NL | 27.03.2002 | ||
DK | 27.06.2002 | ||
PT | 27.06.2002 | ||
SE | 27.06.2002 | ||
IE | 16.12.2002 | ||
Former [2003/45] | AT | 27.03.2002 | |
BE | 27.03.2002 | ||
CH | 27.03.2002 | ||
GR | 27.03.2002 | ||
LI | 27.03.2002 | ||
NL | 27.03.2002 | ||
DK | 27.06.2002 | ||
PT | 27.06.2002 | ||
SE | 27.06.2002 | ||
Former [2003/21] | AT | 27.03.2002 | |
BE | 27.03.2002 | ||
CH | 27.03.2002 | ||
GR | 27.03.2002 | ||
LI | 27.03.2002 | ||
NL | 27.03.2002 | ||
PT | 27.06.2002 | ||
SE | 27.06.2002 | ||
Former [2003/19] | AT | 27.03.2002 | |
BE | 27.03.2002 | ||
CH | 27.03.2002 | ||
GR | 27.03.2002 | ||
LI | 27.03.2002 | ||
NL | 27.03.2002 | ||
SE | 27.06.2002 | ||
Former [2003/16] | AT | 27.03.2002 | |
BE | 27.03.2002 | ||
CH | 27.03.2002 | ||
LI | 27.03.2002 | ||
NL | 27.03.2002 | ||
SE | 27.06.2002 | ||
Former [2003/09] | AT | 27.03.2002 | |
BE | 27.03.2002 | ||
NL | 27.03.2002 | ||
SE | 27.06.2002 | ||
Former [2003/06] | BE | 27.03.2002 | |
NL | 27.03.2002 | ||
SE | 27.06.2002 | ||
Former [2002/37] | SE | 27.06.2002 | Cited in | International search | [X]EP0533280 (GLAXO GROUP LTD [GB]) [X] 1* claims 1-3 *; | [X]EP0615751 (GLAXO GROUP LTD [GB]) [X] 1 * claims 1-3 *; | [X] - TATTERSALL F D ET AL, "Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin-1 receptor antagonist CP-99,994", NEUROPHARMACOLOGY, 33 (2). 15-03-1994. 259-260., XP000570654 [X] 1-18 * abstract * DOI: http://dx.doi.org/10.1016/0028-3908(94)90018-3 | [X] - BOUNTRA C ET AL, "Anti-emetic profile of a non-peptide neurokinin NK-1 receptor antagonist, CP-99,994, in ferrets", EUROPEAN JOURNAL OF PHARMACOLOGY, 249 (1). 1993. R3-R4., XP000571021 [X] 1-18 * abstract * DOI: http://dx.doi.org/10.1016/0014-2999(93)90673-6 | Examination | - Maldonado R. et al.: Neuroscience Letters, 156 (1993), 135-140 | - Murtra P. et al.: Nature, 405 (2000), 180-183 |